Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 4, 2010, Pages 364-369

  Crosby, Marcus A ^a   Tward, Jonathan D ^b   Szabo, Aniko ^a   Lee, Christopher M ^c   Gaffney, David K ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Cancer Care Northwest ^*  (United States)

Author keywords

Brachytherapy; Endometrial cancer; Radiation therapy

Indexed keywords

ADULT; ARTICLE; BRACHYTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HIGH RISK PATIENT; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; NEGRO; OVERALL SURVIVAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; UNITED STATES; ENDOMETRIUM TUMOR; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; ONSET AGE; PATHOLOGY; RADIOTHERAPY; SURVIVAL RATE; UTERUS CANCER;

AGE OF ONSET; BRACHYTHERAPY; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; SEER PROGRAM; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 77956628579     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181b0c266     Document Type: Article

References (25)

1. Ries LAG, Melbert D, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute. Available at: Http:// seer.cancer.gov/statfacts/html/corp.html. Accessed February 9, 2009.
2. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404-1411.
3. Lee CM, Szabo A, Shrieve DC, et al. Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population study. Cancer. 2007;110:2092-2100.
4. Small W Jr, Erickson B, Kwakwa F. An American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer [Abstract]. Int J Radiat Oncol Biol Phys. 2004;60:S211.
5. Cozad SC. Stage II adenocarcinoma of the endometrium: Adjuvant radiotherapy and recurrence patterns. Int J Radiat Oncol Biol Phys. 2008;71:205-212.
6. Greven KM, D'Agostino RB Jr, Lanciano RM, et al. Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterineconfined endometrial cancer? Int J Radiat Oncol Biol Phys. 1998;42:101-104.
7. Irwin C, Levin W, Fyles A, et al. The role of adjuvant radiotherapy in carcinoma of the endometrium-results in 550 patients with pathologic stage I disease. Gynecol Oncol. 1998;70:247-254.
8. Pitson G, Colgan T, Levin W, et al. Stage II endometrial carcinoma: Prognostic factors and risk classification in 170 patients. Int J Radiat Oncol Biol Phys. 2002;53:862-867.
9. Randall ME, Wilder J, Greven K, Raben M. Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma. Int J Radiat Oncol Biol Phys. 1990;19:49-54.
10. Lachance JA, Stukenborg GJ, Schneider BF, et al. A cost-effective analysis of adjuvant therapies for the treatment of stage I endometrial adenocarcinoma. Gynecol Oncol. 2008;108:77-83.
11. Aalders J, Abeler V, Kolstad P, et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients. Obstet Gynecol. 1980;56:419-427.
12. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744-751.
13. ASTEC Investigators. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN 5 randomised trials): Pooled trial results, systematic review, and meta-analysis. Lancet. 2009;373:137-146.
14. Lee CM, Szabo A, Shrieve DC, et al. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA. 2006;295:389-397. (Pubitemid 43144975)
15. Stryker JA, Podczaski E, Kaminski P, et al. Adjuvant external beam therapy for pathologic stage I and occult stage II endometrial carcinoma. Cancer. 1991;67:2872-2879.
16. Larson DM, Copeland LJ, Gallager HS, et al. Nature of cervical involvement in endometrial carcinoma. Cancer. 1987;59:959-962.
17. Kucera H, Vavra N, Weghaupt K. Benefit of external irradiation in pathologic stage I endometrial carcinoma: A prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors. Gynecol Oncol. 1990;38:99-104.
18. Alektiar KM, Venkatraman E, Chi DS, et al. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys. 2005;62:111-117.
19. Chong I, Hoskin PJ. Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer. Brachytherapy. 2008;7:195-199.
20. Horowitz NS, Peters WA III, Smith MR, et al. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma. Obstet Gynecol. 2002;99:235-240.
21. Kong A, Johnson N, Cornes P, et al. Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev. 2007:CD003916.
22. Nout RA, Putter H, Jürgenliemk-Schulz IM, et al. Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: Results of the randomized PORTEC-2 trial. J Clin Oncol. 2008;26:LBA5503.
23. Andersen ES. Stage II endometrial carcinoma: Prognostic factors and the results of treatment. Gynecol Oncol. 1990;38:220-223.
24. Lanciano RM, Curran WJ Jr, Greven KM, et al. Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium. Gynecol Oncol. 1990;39:368-373.
25. Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: The Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol. 2004;22:1234-1241.